Abiopharma

🔍 Krishnamurthy Balaji (A) (Executive)

Company: Uber Technologies, Inc (UBER)

Report Date: 2026-08-16

Detailed Transactions and Holdings:

• Acquired 566 shares of Common Stock (Direct)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 39,825.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 885 shares of Common Stock (Direct)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 40,710.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 687 shares of Common Stock (Direct)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 41,397.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 490 shares of Common Stock (Direct)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 41,887.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,158 shares of Common Stock (Direct)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 43,045.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 607 shares of Common Stock (Direct)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 43,652.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 281 shares of Common Stock at $75.95 per share (Direct)
  Date: 2026-08-16 | Code: F | equity_swap_involved: false | shares_owned_after: 43,371.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 439 shares of Common Stock at $75.95 per share (Direct)
  Date: 2026-08-16 | Code: F | equity_swap_involved: false | shares_owned_after: 42,932.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 341 shares of Common Stock at $75.95 per share (Direct)
  Date: 2026-08-16 | Code: F | equity_swap_involved: false | shares_owned_after: 42,591.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 245 shares of Common Stock at $75.95 per share (Direct)
  Date: 2026-08-16 | Code: F | equity_swap_involved: false | shares_owned_after: 42,346.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 609 shares of Common Stock at $75.95 per share (Direct)
  Date: 2026-08-16 | Code: F | equity_swap_involved: false | shares_owned_after: 41,737.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 332 shares of Common Stock at $75.95 per share (Direct)
  Date: 2026-08-16 | Code: F | equity_swap_involved: false | shares_owned_after: 41,405.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 566 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 65,139.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3
• Sold 885 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 38,057.00 | transaction_form_type: 4 | Footnotes: F1, F4, F4
• Sold 687 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 21,290.00 | transaction_form_type: 4 | Footnotes: F1, F5, F5
• Sold 490 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 9,310.00 | transaction_form_type: 4 | Footnotes: F1, F6, F6
• Sold 1,158 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 15,053.00 | transaction_form_type: 4 | Footnotes: F1, F7, F7
• Sold 607 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 4,244.00 | transaction_form_type: 4 | Footnotes: F1, F8, F8

Footnotes:

• F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
• F2: Shares withheld to satisfy tax liability upon vesting of RSUs on August 16, 2026.
• F3: The reporting person was granted 67,971 RSUs on March 2, 2026. The vesting schedule is as follows: 1/120th of the total RSUs vest each month for 12 months beginning on April 16, 2026, 1/40th vest of the total RSUs vest each month thereafter for 12 months, and 1/20th of the RSUs vest each month thereafter for 12 months. Upon vesting, the RSUs become payable in cash or common stock on a one-for-one basis at the election of the Issuer.
• F4: The reporting person was granted 42,482 RSUs on March 2, 2026. The vesting schedule is as follows: 1/48 of the total RSUs vested on April 16, 2026, and 1/48 of the total RSUs vest each month thereafter. Upon vesting, the RSUs become payable in cash or common stock on a one-for-one basis at the election of the Issuer.
• F5: The reporting person was granted 32,965 RSUs on March 3, 2025. The vesting schedule is as follows: 1/48 of the total RSUs vested on April 16, 2025 and 1/48 of the total RSUs vest each month thereafter. Upon vesting, the RSUs become payable in cash or common stock on a one-for-one basis at the election of the Issuer.
• F6: The reporting person was granted 23,519 RSUs on March 18, 2024. The vesting schedule is as follows: 1/48 of the total RSUs vested on April 16, 2024 and 1/48 of the total RSUs vest each month thereafter. Upon vesting, the RSUs become payable in cash or common stock on a one-for-one basis at the election of the Issuer.
• F7: The reporting person was granted 55,581 RSUs on September 22, 2023. The vesting schedule is as follows: 1/48 of the total RSUs vested on October 16, 2023 and 1/48 of the total RSUs vest each month thereafter. Upon vesting, the RSUs become payable in cash or common stock on a one-for-one basis at the election of the Issuer.
• F8: The reporting person was granted 29,104 RSUs on March 16, 2023. The vesting schedule is as follows: 1/48 of the total RSUs vested on April 16, 2023 and 1/48 of the total RSUs vest each month thereafter. Upon vesting, the RSUs become payable in cash or common stock on a one-for-one basis at the election of the Issuer.